Found 463 results in Expert Content

In this webinar experts will discuss a unique approach that integrates advanced formulation expertise with on-demand Phase 1 clinical manufacturing, adaptive clinical testing, statistical and regulatory support to help achieve flexible and efficient First-in-Human studies and fast development for challenging molecules.

In this webinar, experts review the definition of integrated solutions in the pharmaceutical industry, discuss the benefit and challenges of these integrated approaches and provide insights on whether integrated solutions can be the key to achieving development milestones.

This webinar will discuss challenges and key considerations for spray-dried formulations for inhalation, along with a review of current technologies and approved products utilizing particle engineering approaches.

In this webinar, experts will discuss a unique approach that integrates advanced formulation expertise with on-demand phase I clinical manufacturing, adaptive clinical testing, and regulatory support.

Summary: In this webinar, participants will both hear a panel of industry experts discuss practical challenges in oral drug development and gain valuable insights into current approaches to overcoming challenges in developing oral dosage forms that are more patient-friendly.

Summary: Learn more about orally disintegrating tablets as a solution to various factors that impact treatment adherence rates across various diseases.

Summary: Learn more about developing intranasal products, advantages of intranasal vaccines & the considerations and challenges associated with this delivery route.

Read this case study to learn more about Catalent's partnership with Clarus to develop a unique and convenient drug delivery form for their hormone replacement therapy.

Summary: Experts discuss integrated solutions in the pharmaceutical industry and the benefits and challenges of this approach. Is this the key to more aggressive development milestones?

Summary: Listen in as Mike and Darren share how new modalities and manufacturing technologies have altered the partnership landscape between developers and CDMOs.